You are here

AN ACELLULAR RESUSCITATIVE FLUID

Award Information
Agency: Department of Defense
Branch: Army
Contract: N/A
Agency Tracking Number: 6117
Amount: $41,250.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1987
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
9372 Elm St
Chadwicks, NY 13319
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 LAWRENCE C CERNY
 (315) 733-2217
Business Contact
Phone: () -
Research Institution
N/A
Abstract

DURING THE PAST SEVERAL YEARS, GREAT ADVANCES HAVE BEEN MADE TOWARD THE GOAL OF PRODUCING AN OXYGEN-CARRYING RESUSCITATIVE FLUID, COMMONLY CALLED ARTIFICIAL BLOOD SUBSTITUTE. FROM THE PRELIMINARY STUDIES IN THIS LABORATORY, IT APPEARS FEASIBLE TO SYNTHESIZE A SUITABLE SUBSTANCE IN FREEZE-DRIED FORM. THE ARTIFICIAL BLOOD PROPOSED IN THIS INVESTIGATION CAN BE PRODUCED FROM A STABLIZED TETRAMERIC HEMOGLOBIN AND A MODIFIED HYDROXYETHYL STARCH. THE COMPOUND IN THIS STUDY HAS THE FOLLOWING ADVANTAGES: 1) MADE FROM READILY AVAILABLE AND INEXPENSIVE MATERIALS; 2) THE COMPOSITION IS KNOWN AND CAN BE VARIED TO MEET SPECIFIC NEEDS; 3) BLOOD TYPING IS UNNCESSARY; 4) NO DANGER OF CONTRACTING HEPATITIS OR TRANSFUSION-TRANSMITTED DISEASES SUCH AS AIDS; 5) LARGE VOLUME USAGE IS PRACTICAL; 6) THE FREEZE-DRIED PRODUCT MAKES STORAGE EASY; 7) THE LONG SHELF-LIFE OF THE PRODUCT MAKES IT VIABLE FOR EXTENDED PERIODS OF TIME, UP TO FIVE YEARS.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government